|
The unintended stimulation/new pain questionnaire was reviewed for potential causes of the reported issue.Based on this review, the questionnaire was completed by quality with limited information.Implanting the device off-label, not performing an x-ray immediately after the procedure to confirm placement, having another non-curonix device implanted, and migration have been ruled out as potential root causes.However, it was noted the patient has severe scarring at the implant site as well as the nerve at the time of the explant procedure.Additionally, the implant procedure was performed by open surgery which included exposure of the nerve and placement of the neurostimulator.Per curonix chief medical officer, general anesthesia can contribute to cholecystitis.Additionally, uncontrolled pain can trigger shingles.However, the chief medical officer does not believe that the device caused the pain.The neurostimulator associated with the complaint was returned for investigation.The investigation found circuit failure.The device failed the automated functional test on stimulator verification unit (tf-0029) and system failure was confirmed.In addition, there was evidence of liquid ingress (i.E.Efflorescence, oxidation) and the electrode wires were damaged due to corrosion.The stimulator is used to treat pain.The cause of the discomfort is due to non-compliance to the ifu as the implant procedure was performed by open surgery (user error-clinician).Additionally, circuit failure was observed as the neurostimulator failed the automated functional test (failure).Rates reviewed at the most recent complaint trending meeting do not indicate a significant increase in unintended stimulation/new pain issues.Unintended stimulation/new pain issue rates remain acceptably low; thus, a capa is not required.Unintended stimulation/new pain issues rates will continue to be tracked and trended.
|